hexvix 85 mg, powder and solvent for intravesical solution
ipsen pharmaceuticals limited - hexaminolevulinate hydrochloride - pdr+solv/soln/intravesical use - 85 milligram(s) - other diagnostic agents
axunio vitamin d3 20 000 i.e. weichkapseln
acure pharmaceuticals limited (1009465) - weichkapsel - 20000 i.e.
axunio vitamin d3 25 000 i.e. weichkapseln
acure pharmaceuticals limited (1009465) - weichkapsel - 25000 i.e.
potassium iodate 85mg tablets
alliance pharmaceuticals ltd - potassium iodate - oral tablet - 85mg
berk
eurofarma laboratÓrios s.a. - acetato de caspofungina - anti-fungicos
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberkulożi, b'resistema multidrug - antimikobatterjali - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberkuloosi, monilääkeresistenssi - mykobakteerilÄÄkkeet - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
caberkana
berkanafarma s.a. [ec] ecuador - cabergolina 0,50 mg - tableta - cada tableta contiene: cabergolina 0,50 mg
aciberkan tabletas recubiertas
berkanafarma s.a. [ec] ecuador - ibandronato sódico monohidratado 169,00 mg (equivalente a 150 mg de ácido ibandrónico) - tabletas recubiertas - cada tableta recubierta contiene: ibandronato sódico monohidratado 169,00 mg (equivalente a 150 mg de ácido ibandrónico)
dovprela (previously pretomanid fgk)
mylan ire healthcare limited - pretomanid - tuberkulóza, multirezistentní - antimykobakteriální látky - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). pozornost by měla být věnována oficiálním doporučením pro správné používání antibakteriálních látek.